iBio, Inc. (NYSE: IBIO), has engaged Caliber Biotherapeutics LLC to scale-up and produce materials for clinical development of the first ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE